 |
Hot Pursuit
15-Jun-24
|
|
|
|
|
|
|
|
|
|
|
|
Biocon’s Andhra Pradesh facility gets 3 USFDA observations
|
|
Biocon said that US Food and Drug Administration (USFDA) issued three observations after the good manufacturing practices (GMP) inspection conducted at its API manufacturing facility situated at Visakhapatnam, Andhra Pradesh.
|
|
|
|
|
|
The good manufacturing practices was conducted on 14 June 2024 and closed the inspection with three observations. The company said that it will respond to the USFDA within the stipulated timeframe.
Biocon is an innovation led global biopharmaceuticals company, engaged in the production of therapies for chronic conditions like diabetes, cancer and autoimmune. It has developed and commercialized novel biologics, biosimilars, and complex small molecule APIs in India and several key global markets as well as Generic Formulations in the US, Europe & key emerging markets. It also has a pipeline of promising novel assets in immunotherapy under development.
The company had reported 56.74% decline in consolidated net profit to Rs 135.5 crore despite of 3.79% rise in revenue from operations to Rs 3,917.1 crore in Q4 FY24 over Q4 FY23.
The scrip fell 1.06% to end at Rs 334.65 on Friday, 15 June 2024.
|
|
|
|
Previous News |
Biocon's biologics arm gets Health Canada approval for aflibercept biosimilar 'Yesafili'
(
Hot Pursuit
-
27-Jun-25
12:18
)
|
|
|
Biocon raises Rs 4,500 crore via QIP
(
Hot Pursuit
-
21-Jun-25
09:13
)
|
|
|
Restaurant Brands Asia Ltd leads gainers in 'A' group
(
Hot Pursuit
-
19-Jun-25
12:00
)
|
|
|
Biocon get facilities rated
(
Corporate News
-
18-Jun-25
09:41
)
|
|
|
Indices drift lower in early trade; breadth positive
(
Market Commentary
-
Mid-Session
17-Jun-25
09:37
)
|
|
|
Biocon Ltd soars 3.52%, Gains for third straight session
(
Hot Pursuit
-
11-Jun-25
13:05
)
|
|
|
Biocon gets CDSCO approval for Liraglutide drug substance
(
Hot Pursuit
-
03-Jun-25
08:23
)
|
|
|
Biocon Biologics announces extension of insulin supply agreement with Govt. of Malaysia
(
Corporate News
-
22-May-25
09:19
)
|
|
|
Biocon Ltd spurts 1.3%, up for five straight sessions
(
Hot Pursuit
-
19-May-25
13:00
)
|
|
|
Biocon's subsidiary get US FDA nod for anticoagulant medication Rivaroxaban
(
Hot Pursuit
-
16-May-25
09:38
)
|
|
|
Biocon
(
Results
-
Analysis
09-May-25
10:36
)
|
|
|
|
|
|
Other Stories |
|
|
|
|
|
|
|
|
|
|
|
|
|